About: Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?   Goto Sponge  NotDistinct  Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

AttributesValues
type
isDefinedBy
has title
  • Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
Creator
  • Andò, Giuseppe
  • Crisafulli, Salvatore
  • Drago, Filippo
  • Racagni, Giorgio
  • Trifirò, Gianluca
Source
  • Medline; PMC
abstract
has issue date
bibo:doi
  • 10.1007/s40264-020-00935-2
bibo:pmid
  • 32303915
has license
  • no-cc
sha1sum (hex)
  • a723fbd68f4a132a621a72a29f79a0f99bd68001
schema:url
resource representing a document's title
has PubMed Central identifier
  • PMC7164333
has PubMed identifier
  • 32303915
schema:publication
  • Drug Saf
resource representing a document's body
is schema:about of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software